Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Soucek

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
General Physiology and Biophysics|October 28, 1998
Peptidomimetic inhibitors complexed with HIV-1 protease: crystallisation for X-ray diffraction studiesJ Dohnálek, J Hasek, J Brynda, et al.
Leukemia|April 1, 1997
Peptide inhibitors of HIV-1 and HIV-2 proteases: a comparative studyI Pichová, J Weber, J Litera, et al.
Kidney International|June 2, 1998
Angiotensin I-converting enzyme and angiotensinogen gene interaction and prediction of essential hypertensionA Vasků, M Soucek, V Znojil, et al.
Vnitrni Lekarstvi|December 8, 2004
[Recommendations for diagnostics and treatment of arterial hypertension--version 2004. Recommendations of the Czech Society for Prevention of Hypertension]R Cífková, K Horký, J Widimský, et al.
Vnitrni Lekarstvi|April 9, 2008
[Recommended diagnostic and therapeutic approach in arterial hypertension--2007 version. Recommendations of the Czech Hypertension Society]J Widimský, R Cífková, J Spinar, et al.
Journal of Clinical Pharmacology|August 16, 2001
Oral bioavailability and disposition of [14C]omapatrilat in healthy subjectsB K Malhotra, R A Iyer, K M Soucek, et al.
Archives of Biochemistry and Biophysics|May 1, 1997
Potency comparison of peptidomimetic inhibitors against HIV-1 and HIV-2 proteinases: design of equipotent lead compoundsJ Weber, P Majer, J Litera, et al.
European Journal of Biochemistry|January 15, 1998
Configurations of diastereomeric hydroxyethylene isosteres strongly affect biological activities of a series of specific inhibitors of human-immunodeficiency-virus proteinaseJ Konvalinka, J Litera, J Weber, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
General Physiology and Biophysics|October 28, 1998
Peptidomimetic inhibitors complexed with HIV-1 protease: crystallisation for X-ray diffraction studiesJ Dohnálek, J Hasek, J Brynda, et al.
Leukemia|April 1, 1997
Peptide inhibitors of HIV-1 and HIV-2 proteases: a comparative studyI Pichová, J Weber, J Litera, et al.
Kidney International|June 2, 1998
Angiotensin I-converting enzyme and angiotensinogen gene interaction and prediction of essential hypertensionA Vasků, M Soucek, V Znojil, et al.
Vnitrni Lekarstvi|December 8, 2004
[Recommendations for diagnostics and treatment of arterial hypertension--version 2004. Recommendations of the Czech Society for Prevention of Hypertension]R Cífková, K Horký, J Widimský, et al.
Vnitrni Lekarstvi|April 9, 2008
[Recommended diagnostic and therapeutic approach in arterial hypertension--2007 version. Recommendations of the Czech Hypertension Society]J Widimský, R Cífková, J Spinar, et al.
Journal of Clinical Pharmacology|August 16, 2001
Oral bioavailability and disposition of [14C]omapatrilat in healthy subjectsB K Malhotra, R A Iyer, K M Soucek, et al.
Archives of Biochemistry and Biophysics|May 1, 1997
Potency comparison of peptidomimetic inhibitors against HIV-1 and HIV-2 proteinases: design of equipotent lead compoundsJ Weber, P Majer, J Litera, et al.
European Journal of Biochemistry|January 15, 1998
Configurations of diastereomeric hydroxyethylene isosteres strongly affect biological activities of a series of specific inhibitors of human-immunodeficiency-virus proteinaseJ Konvalinka, J Litera, J Weber, et al.
Pageof 10